---
$id: https://graph.org.ai/products/commodity/51101903
$type: Product
source: UNSPSC
code: "51101903"
title: "Primaquine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Primaquine

**UNSPSC Code**: 51101903
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent with the molecular formula C15H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MVR3634GX1, chemically known as 1,4-pentanediamine, n4-(6-methoxy-8-quinolinyl)- (9ci) but generally known as primaquine, which bears US NIH Compound Identifier 4908. European Medicines Agency schedules Primaquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10043MIG. The term PRIMAQUINE is an International Non-Proprietary Name. World Health Organization schedules primaquine in its Anatomical Therapeutic Chemical (ATC) Classification. PRIMAQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule primaquine under HS 29334990 and SITC 51575. As of Q4 2014, PRIMAQUINE remains the US FDA Preferred Term for this commodity. Primaquine bears US NLM identifiers UMLS ID C0033126 and NCI Concept Code C62071. SMILES: O(C1CC(NC(CCCN)C)C2NCCCC2C1)C.

